Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho

PLoS Medicine ◽

10.1371/journal.pmed.1003325 ◽

2020 ◽

Vol 17 (9) ◽

pp. e1003325

Author(s):

Alain Amstutz ◽

Bienvenu Lengo Nsakala ◽

Fiona Vanobberghen ◽

Josephine Muhairwe ◽

Tracy Renée Glass ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

Low Level ◽

Randomized Controlled ◽

Download Full-text

Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial

Antiviral Therapy ◽

10.3851/imp3171 ◽

2017 ◽

Vol 23 (1) ◽

pp. 21-32 ◽

Author(s):

Amanda H Yao ◽

◽

Cecilia L Moore ◽

Poh Lian Lim ◽

Jean-Michel Molina ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Metabolic Profiles ◽

Second Line ◽

Randomized Controlled ◽

First Line Therapy ◽

Line Therapy ◽

Hiv 1 ◽

Second Line Antiretroviral Therapy

Download Full-text

Faculty Opinions recommendation of Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954092.793459874 ◽

2012 ◽

Author(s):

Joe Eron ◽

Christopher Hurt

Keyword(s):

Randomized Controlled Trial ◽

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

Randomized Controlled ◽

Second Line Antiretroviral Therapy

Download Full-text

TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-016-1392-3 ◽

2016 ◽

Vol 17 (1) ◽

Author(s):

Matthew B. Laurens ◽

Randy G. Mungwira ◽

Osward M. Nyirenda ◽

Titus H. Divala ◽

Maxwell Kanjala ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Antiretroviral Therapy ◽

Study Protocol ◽

Controlled Trial ◽

Randomized Controlled ◽

Open Label Trial

Download Full-text

Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA)

Antiviral Therapy ◽

10.3851/imp2253 ◽

2012 ◽

Vol 17 (7) ◽

pp. 1363-1373 ◽

Author(s):

Charles F Gilks ◽

◽

A Sarah Walker ◽

David T Dunn ◽

Diana M Gibb ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

Randomized Controlled ◽

Second Line Antiretroviral Therapy

Download Full-text

Clinical Efficacy and Safety of Injectable Levetiracetam Versus Phenytoin as Second-Line Therapy in the Management of Generalized Convulsive Status Epilepticus in Children: An Open-Label Randomized Controlled Trial

Journal of Clinical Neurology ◽

10.3988/jcn.2019.15.4.468 ◽

2019 ◽

Vol 15 (4) ◽

pp. 468 ◽

Author(s):

Nuzhat Noureen ◽

Saadia Khan ◽

Asim Khursheed ◽

Imran Iqbal ◽

Moallah Maryam ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Status Epilepticus ◽

Controlled Trial ◽

Convulsive Status Epilepticus ◽

Second Line ◽

Efficacy And Safety ◽

Second Line Therapy ◽

Randomized Controlled ◽

Download Full-text

Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

Investigational New Drugs ◽

10.1007/s10637-014-0117-2 ◽

2014 ◽

Vol 32 (6) ◽

pp. 1278-1284 ◽

Author(s):

A. Ruzsa ◽

◽

M. Sen ◽

M. Evans ◽

L. W. Lee ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Controlled Trial ◽

Cell Carcinoma ◽

Head And Neck ◽

Controlled Trial ◽

Second Line ◽

Phase 2 ◽

Randomized Controlled ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Open-Label Randomized Controlled Trial of Vonoprazan and Esomeprazole in First-Line Triple Therapy Against Helicobacter Pylori Infection

Gastroenterology ◽

10.1016/s0016-5085(17)31120-4 ◽

2017 ◽

Vol 152 (5) ◽

pp. S248

Author(s):

Hiroyuki Tamaki ◽

Masahiro Morita ◽

Teruyo Noda ◽

Masako Izuta ◽

Atsushi Kubo ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Helicobacter Pylori Infection ◽

Randomized Controlled

Download Full-text

Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial

Medicine ◽

10.1097/md.0000000000013245 ◽

2018 ◽

Vol 97 (46) ◽

pp. e13245 ◽

Author(s):

Hyun Lim ◽

Chang Seok Bang ◽

Woon Geon Shin ◽

Jae Ho Choi ◽

Jae Seung Soh ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Helicobacter Pylori ◽

Controlled Trial ◽

Line Treatment ◽

Quadruple Therapy ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

First Line Treatment

Download Full-text

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

PLoS Medicine ◽

10.1371/journal.pmed.1000321 ◽

2010 ◽

Vol 7 (8) ◽

pp. e1000321 ◽

Author(s):

Rajesh T. Gandhi ◽

Lu Zheng ◽

Ronald J. Bosch ◽

Ellen S. Chan ◽

David M. Margolis ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Antiretroviral Therapy ◽

Controlled Trial ◽

Residual Viremia ◽

Low Level ◽

Randomized Controlled

Download Full-text

An open-label, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for Helicobacter pylori infection

10.26226/morressier.59a6b345d462b80290b547bd ◽

2017 ◽

Author(s):

Hiroyuki Tamaki

Keyword(s):

Randomized Controlled Trial ◽

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Helicobacter Pylori Infection ◽

Randomized Controlled

Download Full-text